Profile data is unavailable for this security.
About the company
Phase Holographic Imaging PHI AB (PHI) is a Sweden-based company active in the field of medical technology. It develops and markets time-lapse cytometers for clinical applications. The products use holographic microscopy technology, with image sensors capturing light information from objects, and computer processing the information to create visual image. It is also engaged in the development of related software. Its method allows to view and measure living cell over time, without disturbing or destroying it. PHI collaborates with cancer- and stem cell researchers, among others. The Company’s product portfolio includes HoloMonitor M3, a bench-top time-lapse cytometer, and HoloMonitor M4, allowing cell analysis in the cultivation incubator.
- Revenue in SEK (TTM)9.12m
- Net income in SEK-21.81m
- Incorporated1997
- Employees14.00
- LocationPhase Holographic Imaging PHI ABSkiffervagen 48LUND 224 78SwedenSWE
- Phone+46 46386080
- Websitehttps://phiab.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBS-Bioactive Bone Substitutes Oyj | 0.00 | -41.19m | 28.58m | -- | -- | 0.5269 | -- | -- | -0.2069 | -0.2069 | 0.00 | 0.1765 | 0.00 | -- | -- | -- | -35.38 | -25.12 | -45.41 | -28.54 | -- | -- | -- | -- | -- | -27.51 | 0.5953 | -- | -- | -- | -12.64 | -- | -- | -- |
| ProstaLund AB | 16.22m | -19.84m | 28.67m | 7.00 | -- | 0.4951 | -- | 1.77 | -0.2328 | -0.2328 | 0.1807 | 0.4706 | 0.243 | 0.3281 | 6.67 | -- | -29.73 | -29.14 | -33.53 | -35.01 | 70.50 | 75.26 | -122.35 | -68.94 | 2.60 | -135.86 | 0.0175 | -- | 27.54 | 10.36 | -53.27 | -- | 20.35 | -- |
| Inhalation Sciences Sweden AB | 15.48m | -3.93m | 31.55m | 8.00 | -- | 2.81 | -- | 2.04 | -0.2796 | -0.2796 | 1.09 | 0.7409 | 0.8096 | 0.6328 | 4.37 | 1,935,000.00 | -20.53 | -27.93 | -29.23 | -43.82 | 86.29 | 71.13 | -25.36 | -48.02 | 2.81 | -6.49 | 0.0639 | -- | 43.55 | 26.33 | 60.87 | -- | -- | -- |
| Bio Vitos Pharma AB | 1.01m | -15.13m | 32.78m | 1.00 | -- | 0.8735 | -- | 32.43 | -0.7859 | -0.7859 | 0.0393 | 0.9525 | 0.0271 | 0.2064 | 19.99 | 1,010,830.00 | -40.53 | -31.11 | -54.83 | -32.92 | 89.68 | -- | -1,496.73 | -1,026.76 | 2.28 | -- | 0.00 | -- | 126.97 | -- | 13.64 | -- | -- | -- |
| PMD Device Solutions AB | 51.91m | -43.42m | 33.21m | 37.00 | 0.2528 | -- | -- | 0.6397 | 5.06 | 5.06 | 3.54 | -5.52 | 0.8624 | -- | 4.47 | -- | -72.13 | -- | -- | -- | 82.86 | -- | -83.64 | -- | 0.1121 | -1.88 | -- | -- | -- | -- | -- | -- | -- | -- |
| Scandinavian ChemoTech AB | 5.03m | -15.70m | 37.74m | 5.00 | -- | 4.53 | -- | 7.50 | -0.8655 | -0.8655 | 0.2647 | 0.384 | 0.3162 | 0.5947 | 1.37 | 838,666.70 | -98.64 | -87.29 | -98.64 | -118.55 | 29.67 | 252.05 | -311.96 | -2,122.77 | -- | -22.93 | 0.00 | -- | 496.62 | 19.13 | 7.28 | -- | -- | -- |
| Scandinavian Real Heart AB | 0.00 | -75.02m | 37.85m | 12.00 | -- | 0.4136 | -- | -- | -51.82 | -51.82 | 0.00 | 44.25 | 0.00 | -- | -- | 0.00 | -73.46 | -24.27 | -87.03 | -26.81 | -- | 832.41 | -- | -6,070.11 | -- | -700.38 | 0.1023 | -- | -100.00 | -- | -385.97 | -- | -25.76 | -- |
| Phase Holographic Imaging PHI AB | 9.12m | -21.81m | 52.19m | 14.00 | -- | -- | -- | 5.72 | -0.8695 | -0.8695 | 0.3634 | -0.0273 | 0.2373 | 0.6598 | 1.18 | 651,571.40 | -56.73 | -62.04 | -88.25 | -79.16 | 71.06 | 63.16 | -239.04 | -328.50 | 0.1916 | -5.61 | 1.04 | -- | 6.16 | 17.96 | 12.98 | -- | 22.76 | -- |
| Clinical Laserthermia Systems AB | 18.63m | -64.20m | 52.65m | 7.00 | -- | 0.862 | -- | 2.83 | -7.93 | -7.93 | 2.05 | 4.39 | 0.265 | 7.62 | 5.22 | -- | -92.16 | -123.49 | -103.14 | -312.95 | -175.42 | -1,084.16 | -347.76 | -1,625.03 | 2.39 | -11.71 | 0.0077 | -- | 31.99 | 35.55 | -12.92 | -- | 18.26 | -- |
| iZafe Group AB | 6.29m | -31.99m | 55.00m | 7.00 | -- | 3.53 | -- | 8.75 | -0.1319 | -0.1319 | 0.0259 | 0.0567 | 0.1602 | 3.25 | 12.26 | 898,285.70 | -81.49 | -52.17 | -100.43 | -69.40 | -116.33 | -198.20 | -508.73 | -487.50 | 0.4406 | -43.46 | 0.3159 | -- | 149.93 | -24.79 | -36.76 | -- | -41.66 | -- |
| ScandiDos AB | 61.35m | -9.67m | 74.80m | 26.00 | -- | 2.14 | -- | 1.22 | -0.2068 | -0.2068 | 1.26 | 0.766 | 0.8184 | 1.31 | 6.88 | 1,978,871.00 | -12.90 | -12.60 | -23.54 | -21.76 | 50.39 | 51.58 | -15.76 | -15.37 | 0.9476 | -6.36 | 0.00 | -- | -1.82 | 4.36 | -60.62 | -- | -19.29 | -- |
Data as of Nov 22 2024. Currency figures normalised to Phase Holographic Imaging PHI AB's reporting currency: Swedish Krona SEK
